These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Botulinum toxin in movement disorders. Papapetropoulos S; Singer C Semin Neurol; 2007 Apr; 27(2):183-94. PubMed ID: 17390263 [TBL] [Abstract][Full Text] [Related]
24. The role of Botulinum toxin injection in the management of achalasia. Ramzan Z; Nassri AB Curr Opin Gastroenterol; 2013 Jul; 29(4):468-73. PubMed ID: 23695428 [TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations. Tan EK Eur J Neurol; 2006 Feb; 13 Suppl 1():60-4. PubMed ID: 16417600 [TBL] [Abstract][Full Text] [Related]
26. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B. Wilken B; Aslami B; Backes H Neuropediatrics; 2008 Aug; 39(4):200-4. PubMed ID: 19165707 [TBL] [Abstract][Full Text] [Related]
27. [Botulinum toxin in the treatment of cerebral palsy: case conference]. Nezu A; Takahashi Y No To Hattatsu; 2011 Mar; 43(2):136-8. PubMed ID: 21409836 [No Abstract] [Full Text] [Related]
29. Botulinum toxin treatment in cerebral palsy: intervention with poor evaluation? Forssberg H; Tedroff KB Dev Med Child Neurol; 1997 Sep; 39(9):635-40. PubMed ID: 9344058 [No Abstract] [Full Text] [Related]
30. Botulinum toxin type B for sialorrhea in children with cerebral palsy. Reddihough D; Graham HK Dev Med Child Neurol; 2011 Jun; 53(6):488-9. PubMed ID: 21501158 [No Abstract] [Full Text] [Related]
31. Injection of botulinum toxin type B for the treatment of otolaryngology patients with secondary treatment failure of botulinum toxin type A. Guntinas-Lichius O Laryngoscope; 2003 Apr; 113(4):743-5. PubMed ID: 12671439 [No Abstract] [Full Text] [Related]
32. Botulinum toxin for spasmodic dysphonia. Rodriquez AA Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):767-79. PubMed ID: 14580036 [TBL] [Abstract][Full Text] [Related]
33. [Treatment of spasticity with injections of botulinum toxin. Review of the literature]. Fève A; Decq P; Filipetti P; Kéravel Y Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435 [TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin as a treatment for tardive dyskinesia. van Harten PN; Hovestadt A Mov Disord; 2006 Aug; 21(8):1276-7. PubMed ID: 16671083 [TBL] [Abstract][Full Text] [Related]
35. Botulinum toxin: a case study. Streeter BL Gastroenterol Nurs; 1999; 22(2):59-61. PubMed ID: 10382413 [TBL] [Abstract][Full Text] [Related]
36. An update on the neurologic applications of botulinum toxins. Evidente VG; Adler CH Curr Neurol Neurosci Rep; 2010 Sep; 10(5):338-44. PubMed ID: 20567945 [TBL] [Abstract][Full Text] [Related]
37. Necrotising fasciitis as a complication of botulinum toxin injection. Latimer PR; Hodgkins PR; Vakalis AN; Butler RE; Evans AR; Zaki GA Eye (Lond); 1998; 12 ( Pt 1)():51-3. PubMed ID: 9614517 [TBL] [Abstract][Full Text] [Related]
38. [Treatment with botulinum toxin in neurologic pediatrics]. Justus N; Lee SH; Berweck S; Heinen F Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921 [No Abstract] [Full Text] [Related]
40. Botulinum toxin treatment of children with cerebral palsy - a short review of different injection techniques. Schroeder AS; Berweck S; Lee SH; Heinen F Neurotox Res; 2006 Apr; 9(2-3):189-96. PubMed ID: 16785117 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]